Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Aliment Pharmacol Ther. 2011 Nov 30;35(2):255–265. doi: 10.1111/j.1365-2036.2011.04926.x

Figure 3.

Figure 3

Baseline and subsequent serum levels, expressed as mol%, of select fatty acids over the course of treatment for BIDMC subjects only. At the 2 month follow-up visit, DHA is significantly higher, while, AA is lower compared to baseline. No changes are observed at 12 months compared to baseline for EPA and LA.